136 related articles for article (PubMed ID: 29843550)
1. The polymorphisms of growth factor genes (VEGFA & EGF) were associated with response to acitretin in psoriasis.
Chen W; Wu L; Zhu W; Chen X
Per Med; 2018 May; 15(3):181-188. PubMed ID: 29843550
[TBL] [Abstract][Full Text] [Related]
2. VDR gene polymorphisms are associated with the clinical response to calcipotriol in psoriatic patients.
Zhao Y; Chen X; Li J; He Y; Su J; Chen M; Zhang W; Chen W; Zhu W
J Dermatol Sci; 2015 Sep; 79(3):305-7. PubMed ID: 26169344
[No Abstract] [Full Text] [Related]
3. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy.
Rim JH; Park JY; Choe YB; Youn JI
Am J Clin Dermatol; 2003; 4(7):507-10. PubMed ID: 12814339
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) gene polymorphisms (rs699947, rs833061, and rs2010963) and psoriatic risk in South Indian Tamils.
Sudhesan A; Rajappa M; Chandrashekar L; Ananthanarayanan PH; Thappa DM; Satheesh S; Chandrasekaran A
Hum Immunol; 2017 Oct; 78(10):657-663. PubMed ID: 28803785
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin.
Campalani E; Allen MH; Fairhurst D; Young HS; Mendonca CO; Burden AD; Griffiths CE; Crook MA; Barker JN; Smith CH
Br J Dermatol; 2006 Feb; 154(2):345-52. PubMed ID: 16433808
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to acitretin in psoriasis patients.
Chen W; Zhang X; Zhang W; Peng C; Zhu W; Chen X
Sci Rep; 2018 Sep; 8(1):13182. PubMed ID: 30181619
[TBL] [Abstract][Full Text] [Related]
7. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
[TBL] [Abstract][Full Text] [Related]
8. Genetic association of the epidermal growth factor gene polymorphisms with peri-implantitis risk in Chinese population.
Chang Z; Jiang D; Zhang S; Pei D; Zhang Z; Zhang L; Cai J; Cao J
Bioengineered; 2021 Dec; 12(1):8468-8475. PubMed ID: 34592884
[TBL] [Abstract][Full Text] [Related]
9. Genetic interaction between placental growth factor and vascular endothelial growth factor A in psoriasis.
Young HS; Kamaly-Asl ID; Laws PM; Pemberton P; Griffiths CEM
Clin Exp Dermatol; 2020 Apr; 45(3):302-308. PubMed ID: 31545526
[TBL] [Abstract][Full Text] [Related]
10. Whole Exome Sequencing in Psoriasis Patients Contributes to Studies of Acitretin Treatment Difference.
Zhou X; He Y; Kuang Y; Li J; Zhang J; Chen M; Chen W; Su J; Zhao S; Liu P; Chen M; Shen M; Chen X; Zhu W; Chen X
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146080
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor gene polymorphisms and psoriasis susceptibility: a meta-analysis.
Lee YH; Song GG
Genet Mol Res; 2015 Nov; 14(4):14396-405. PubMed ID: 26600499
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor gene polymorphisms, particularly the novel A-1012G promoter polymorphism, are associated with vitamin D3 responsiveness and non-familial susceptibility in psoriasis.
Halsall JA; Osborne JE; Pringle JH; Hutchinson PE
Pharmacogenet Genomics; 2005 May; 15(5):349-55. PubMed ID: 15864137
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
[TBL] [Abstract][Full Text] [Related]
15. Plexin B2 tissue expression and related gene polymorphisms in psoriasis and their relation to NB-UVB and Acitretin therapy.
Hegazy EM; Taieb MAE; Hassan MH; Ibrahim AK; El-Din EA; Ibrahim HM
Arch Dermatol Res; 2024 May; 316(5):162. PubMed ID: 38734848
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
17. [Interaction analysis between epidermal growth factor and peroxidase proliferators activate receptor-α gene polymorphism and susceptibility to generalized aggressive periodontitis].
Wang XE; Meng HX; Lu RF; Feng XH; Xu L; Shi D
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Jul; 55(7):482-487. PubMed ID: 32634887
[No Abstract] [Full Text] [Related]
18. Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis.
Young HS; Summers AM; Read IR; Fairhurst DA; Plant DJ; Campalani E; Smith CH; Barker JN; Detmar MJ; Brenchley PE; Griffiths CE
J Invest Dermatol; 2006 Feb; 126(2):453-9. PubMed ID: 16385345
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
20. Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis.
Wongpiyabovorn J; Yooyongsatit S; Ruchusatsawat K; Avihingsanon Y; Hirankarn N
Tissue Antigens; 2008 Nov; 72(5):458-63. PubMed ID: 18937791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
